Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Lin

Showing results (151-160 of 287) with videos related to

Pageof 29
Sort By:
Clinical Epigenetics|September 22, 2016
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomyMilan S Geybels, Jonathan L Wright, Marina Bibikova, et al.
Future Oncology (London, England)|August 17, 2016
Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and researchDavid F Penson, Daniel W Lin, Lawrence Karsh, et al.
The Prostate|May 21, 2015
Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohortRohina Rubicz, Shanshan Zhao, Craig April, et al.
The Annals of Applied Statistics|January 11, 2019
ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLSJane M Lange, Roman Gulati, Amy S Leonardson, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
JAMA Oncology|December 12, 2024
Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active SurveillanceLouisa B Goss, Menghan Liu, Yingye Zheng, et al.
The Journal of Urology|May 14, 2013
Follow-up for Clinically Localized Renal Neoplasms: AUA GuidelineSherri M Donat, Mireya Diaz, Jay Todd Bishoff, et al.
The Journal of Urology|May 14, 2013
Castration-resistant prostate cancer: AUA GuidelineMichael S Cookson, Bruce J Roth, Philipp Dahm, et al.
Future Oncology (London, England)|February 9, 2018
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPETScott C Flanders, Janet Kim, Samuel Wilson, et al.
Urology|December 29, 2020
Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015Yaw A Nyame, Sarah K Holt, Leonidas N Diamontopoulos, et al.
Pageof 29

Showing results (151-160 of 287) with videos related to

Sort By:
Pageof 29
Clinical Epigenetics|September 22, 2016
Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomyMilan S Geybels, Jonathan L Wright, Marina Bibikova, et al.
Future Oncology (London, England)|August 17, 2016
Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and researchDavid F Penson, Daniel W Lin, Lawrence Karsh, et al.
The Prostate|May 21, 2015
Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohortRohina Rubicz, Shanshan Zhao, Craig April, et al.
The Annals of Applied Statistics|January 11, 2019
ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLSJane M Lange, Roman Gulati, Amy S Leonardson, et al.
Clinical Genitourinary Cancer|February 25, 2014
Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancerAndrew C James, Franklin C Lee, Jason P Izard, et al.
JAMA Oncology|December 12, 2024
Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active SurveillanceLouisa B Goss, Menghan Liu, Yingye Zheng, et al.
The Journal of Urology|May 14, 2013
Follow-up for Clinically Localized Renal Neoplasms: AUA GuidelineSherri M Donat, Mireya Diaz, Jay Todd Bishoff, et al.
The Journal of Urology|May 14, 2013
Castration-resistant prostate cancer: AUA GuidelineMichael S Cookson, Bruce J Roth, Philipp Dahm, et al.
Future Oncology (London, England)|February 9, 2018
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPETScott C Flanders, Janet Kim, Samuel Wilson, et al.
Urology|December 29, 2020
Social and Clinical Correlates of Neoadjuvant Chemotherapy in Medicare Beneficiaries With Muscle Invasive Bladder Cancer From 2004-2015Yaw A Nyame, Sarah K Holt, Leonidas N Diamontopoulos, et al.
Pageof 29